FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

773881003: Antiparkinson therapeutic role (role)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2019. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3726863016 Antiparkinson therapeutic role en Synonym Active Entire term case insensitive SNOMED CT core module
3726864010 Antiparkinson therapeutic role (role) en Fully specified name Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Antiparkinson therapeutic role Is a Therapeutic role true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Trihexyphenidyl Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Product containing only amantadine in oral dose form (medicinal product form) Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Product containing only apomorphine in parenteral dose form (medicinal product form) Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Product containing only benzatropine in oral dose form (medicinal product form) Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Product containing only benzatropine in parenteral dose form (medicinal product form) Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Product containing only biperiden in oral dose form (medicinal product form) Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Product containing only biperiden in parenteral dose form (medicinal product form) Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Product containing only bromocriptine in oral dose form (medicinal product form) Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Product containing only cabergoline in oral dose form (medicinal product form) Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Product containing only carbidopa and entacapone and levodopa in oral dose form (medicinal product form) Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Product containing only carbidopa and levodopa in enteral dose form (medicinal product form) Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Product containing only carbidopa and levodopa in oral dose form (medicinal product form) Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Product containing only carbidopa in oral dose form (medicinal product form) Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Product containing only entacapone in oral dose form (medicinal product form) Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Product containing only levodopa in oral dose form (medicinal product form) Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Product containing only lisuride in oral dose form (medicinal product form) Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Product containing only opicapone in oral dose form (medicinal product form) Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Product containing only orphenadrine in oral dose form (medicinal product form) Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Product containing only orphenadrine in parenteral dose form (medicinal product form) Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Product containing only pergolide in oral dose form (medicinal product form) Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Product containing only pramipexole in oral dose form (medicinal product form) Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Product containing only procyclidine in oral dose form (medicinal product form) Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Product containing only procyclidine in parenteral dose form (medicinal product form) Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Product containing only rasagiline in oral dose form (medicinal product form) Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Product containing only ropinirole in oral dose form (medicinal product form) Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Product containing only rotigotine in transdermal dose form (medicinal product form) Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Product containing only safinamide in oral dose form (medicinal product form) Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Product containing only selegiline in oral dose form (medicinal product form) Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Product containing only tolcapone in oral dose form (medicinal product form) Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Product containing only trihexyphenidyl in oral dose form (medicinal product form) Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely apomorphine hydrochloride 5 milligram/1 milliliter conventional release solution for injection (clinical drug) Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely apomorphine hydrochloride 10 milligram/1 milliliter conventional release solution for injection (clinical drug) Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely procyclidine hydrochloride 5 milligram/1 milliliter conventional release solution for injection (clinical drug) Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Entacapone Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Levodopa Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Lisuride Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Product containing only metixene (medicinal product) Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Opicapone Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Orphenadrine Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely lisuride maleate 200 microgram/1 each conventional release oral tablet (clinical drug) Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely orphenadrine hydrochloride 50 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely pergolide (as pergolide mesilate) 1 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely pergolide (as pergolide mesilate) 250 microgram/1 each conventional release oral tablet (clinical drug) Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely pergolide (as pergolide mesilate) 50 microgram/1 each conventional release oral tablet (clinical drug) Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely carbidopa (as carbidopa monohydrate) 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) Plays role False Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely carbidopa (as carbidopa monohydrate) 12.5 milligram and levodopa 50 milligram/1 each conventional release oral tablet (clinical drug) Plays role False Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely carbidopa (as carbidopa monohydrate) 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) Plays role False Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely carbidopa (as carbidopa monohydrate) 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet (clinical drug) Plays role False Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Product containing benserazide and levodopa in oral dose form (medicinal product form) Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Product containing only benserazide and levodopa in oral dose form (medicinal product form) Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely selegiline hydrochloride 1.25 milligram/1 each conventional release orodispersible tablet (clinical drug) Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely benserazide 12.5 milligram and levodopa 50 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely benserazide 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Product containing safinamide Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Product containing opicapone Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Product containing safinamide in oral dose form (medicinal product form) Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Product containing opicapone in oral dose form (medicinal product form) Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Product containing carbidopa and levodopa in enteral dose form (medicinal product form) Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely carbidopa (as carbidopa monohydrate) 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet Plays role False Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely carbidopa (as carbidopa monohydrate) 25 milligram and levodopa 100 milligram/1 each prolonged-release oral tablet Plays role False Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely procyclidine hydrochloride 500 microgram/1 milliliter conventional release oral solution Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely procyclidine hydrochloride 1 milligram/1 milliliter conventional release oral solution Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Product containing amantadine in oral dose form (medicinal product form) Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Product containing carbidopa in oral dose form (medicinal product form) Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Product containing bromocriptine in oral dose form (medicinal product form) Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Product containing trihexyphenidyl in oral dose form (medicinal product form) Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Product containing cabergoline in oral dose form (medicinal product form) Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Product containing carbidopa and entacapone and levodopa in oral dose form (medicinal product form) Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Product containing entacapone in oral dose form (medicinal product form) Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Product containing ropinirole in oral dose form (medicinal product form) Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Product containing rasagiline in oral dose form (medicinal product form) Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Product containing pramipexole in oral dose form (medicinal product form) Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Product containing lisuride in oral dose form (medicinal product form) Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Product containing tolcapone in oral dose form (medicinal product form) Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Product containing selegiline in oral dose form (medicinal product form) Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely trihexyphenidyl hydrochloride 1 milligram/1 milliliter conventional release oral solution Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Product containing rotigotine in transdermal dose form (medicinal product form) Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely selegiline hydrochloride 2 milligram/1 milliliter conventional release oral solution Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely amantadine hydrochloride 10 milligram/1 milliliter conventional release oral solution Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely orphenadrine hydrochloride 10 milligram/1 milliliter conventional release oral solution Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Product containing levodopa in oral dose form (medicinal product form) Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Product containing pergolide in oral dose form (medicinal product form) Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Amantadine Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Product containing only benserazide (medicinal product) Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Product containing only benserazide and levodopa (medicinal product) Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Benzatropine Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Biperiden Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Bromocriptine Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Cabergoline Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Carbidopa Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Levodopa + Carbidopa + Entacapone Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Co-careldopa Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely rotigotine 83.333 microgram/1 hour prolonged-release transdermal patch Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely rotigotine 166.667 microgram/1 hour prolonged-release transdermal patch Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely rotigotine 250 microgram/1 hour prolonged-release transdermal patch Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Product containing selegiline in oromucosal dose form (medicinal product form) Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely carbidopa anhydrous (as carbidopa) 18.75 milligram and entacapone 200 milligram and levodopa 75 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely carbidopa anhydrous (as carbidopa) 31.25 milligram and entacapone 200 milligram and levodopa 125 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely carbidopa anhydrous (as carbidopa) 10 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (clinical drug) Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (clinical drug) Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 250 milligram/1 each conventional release orodispersible tablet (clinical drug) Plays role True Antiparkinson therapeutic role Inferred relationship Existential restriction modifier

Start Page 2 of 4 Next End

This concept is not in any reference sets

Back to Start